The stock recovered some of its losses to finally end at Rs 258, down over 2% from the previous close. Around 691,753 shares were traded on the BSE as compared to the two-week daily average traded volumes of 698,158 shares on the BSE.
____________________________________________________
(Updated at 1006hrs)
Glenmark has tumbled on a over 50% drop in Q1 net profit.
The stock today opened at Rs 263. It touched a high of Rs 267 but started slipping thereafter. It plunged 6% to a low of Rs 246 and is now at Rs 251 - down 5%.
Around 111,054 shares have been traded on the BSE so far.
Glenmark Pharmaceuticals recorded a net profit of Rs 53.45 crore for the first quarter, a sharp drop of 53 per cent as compared with Rs 115.37 crore during the corresponding period the previous year.
The consolidated revenue, however, increased 18% to Rs 543.69 crore.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
